Below are the most recent publications written about "Therapies, Investigational" by people in Profiles.
-
Ago Y, Rintz E, Musini KS, Ma Z, Tomatsu S. Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. Int J Mol Sci. 2024 Jan 17; 25(2).
-
Narasimhan B, Aggarwal D, Satish P, Kantharia B, Aronow WS. Postural orthostatic tachycardia syndrome: pathophysiology, management, and experimental therapies. Expert Opin Investig Drugs. 2022 Oct; 31(10):1017-1025.
-
Hou PC, Wang HT, Abhee S, Tu WT, McGrath JA, Hsu CK. Investigational Treatments for Epidermolysis Bullosa. Am J Clin Dermatol. 2021 Nov; 22(6):801-817.
-
Bavaria JE. Quality and Innovation in Cardiothoracic Surgery: Colliding Imperatives? Ann Thorac Surg. 2018 11; 106(5):1276-1282.
-
Altit R, Gray WA. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease. Curr Cardiol Rep. 2017 10 12; 19(11):117.
-
Reilly KM, Kim A, Blakely J, Ferner RE, Gutmann DH, Legius E, Miettinen MM, Randall RL, Ratner N, Jumb? NL, Bakker A, Viskochil D, Widemann BC, Stewart DR. Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. J Natl Cancer Inst. 2017 08 01; 109(8).
-
Waldman SA, Terzic A. Bioinnovation Enterprise: An engine driving breakthrough therapies. Clin Pharmacol Ther. 2016 Jan; 99(1):8-13.
-
Caprioli J, Kim JH, Friedman DS, Kiang T, Moster MR, Parrish RK, Rorer EM, Samuelson T, Tarver ME, Singh K, Eydelman MB. Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2015 Sep; 122(9):1795-801.
-
Waldman SA, Terzic A. Knowledge cycle transforms therapeutic innovation. Clin Pharmacol Ther. 2012 Jan; 91(1):3-8.
-
Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED. Testosterone in prostate cancer: the Bethesda consensus. BJU Int. 2012 Aug; 110(3):344-52.